内镜套扎术联合生长抑素治疗肝硬化并发食管静脉曲张出血患者临床效果和安全性分析*

doi:10.3969/j.issn.1672-5069.2019.02.021

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (2): 236-239.doi: 10.3969/j.issn.1672-5069.2019.02.021

内镜套扎术联合生长抑素治疗肝硬化并发食管静脉曲张出血患者临床效果和安全性分析^*

甘厦,方念,黄神安,程飞,张海丽,万娟

330008 南昌市南昌大学第三附属医院消化科

收稿日期:2018-05-14 出版日期:2019-03-10 发布日期:2019-03-19
通讯作者: 方念,E-mail: 674536878@qq.con
作者简介:甘厦,女36岁,医学硕士,主治医师。主要从事消化科疾病诊治研究。E-mail:674536878@qq.con
基金资助:
*江西省青年科学基金计划项目（编号：20151BAB

Clinical therapeutic efficacy and safety of endoscopic variceal ligation combined with somatostatin in treatment of patients with liver cirrhosis complicated by esophageal variceal bleeding

Gan Xia, Fang Nian, Huang Shen’an, Chen Fei, Zhang Haili, Wan Juan

Department of Gastroenterology,Third Affiliated Hospital,Nanchang University,Nanchang 330008,Jiangxi Province,China

Received:2018-05-14 Online:2019-03-10 Published:2019-03-19

摘要/Abstract

摘要： 目的分析采用内镜下曲张静脉套扎术联合生长抑素治疗肝硬化并发食管静脉曲张破裂出血患者的临床治疗效果和安全性。方法 2015年4月~2017年5月我院收治的肝硬化并发食管静脉曲张破裂出血患者64例,被分为两组,每组32例。在对照组,给予奥美拉唑和奥曲肽治疗,观察组则在上述治疗12 h后,给予内镜下曲张静脉套扎术治疗。结果在治疗1 w末,观察组止血总有效率为100.0%,显著高于对照组的90.6%（P<0.05）,对照组死亡3例;治疗后,观察组肝静脉压力梯度（HVPG）为（6.5±1.0） mmHg,显著低于对照组的（11.9±1.1） mmHg,而RBC为（4.7±0.5）×10¹²/L,Hb为（118.5±23.1） g/L,显著高于对照组[分别为（4.1±0.4）×10¹²/L和（104.4±22.5） g/L,P<0.05]; 观察组止血时间为（1.3±0.4）d、输血量为（1.7±1.0） U、住院日为（20.4±3.5） d,显著短于或少于对照组[分别为（2.8±0.5） d、（2.8±1.5） U和（29.8±4.0） d,P<0.05];进行为期1年的随访,观察组再出血发生率为53.1%,显著低于对照组的86.2%（P<0.05）。结论针对肝硬化并发食管静脉曲张出血患者,采用内镜套扎术联合生长抑素治疗可有效止血,缩短住院时间,止血迅速,治疗后再出血发生率低,且安全性较高。

关键词: 肝硬化, 食管静脉曲张破裂出血, 内镜套扎手术, 生长抑素, 治疗

Abstract: Objective To analyze the clinical efficacy and safety of endoscopic variceal ligation （EVL） combined with somatostatin in treatment of patients with liver cirrhosis complicated by esophageal variceal bleeding （EVB）. Methods 64 patients with liver cirrhosis complicated by EVB were recruited in our hospital between April 2015 and May 2017,and were divided into two groups receiving somatostatin or somatostatin and EVL. Results At the end of one week treatment,the hemostasis in combination group was 100.0%,significantly higher than 90.6% （P<0.05） in the somatostatin-treated patients,and three patients died in the latter;after treatment,the hepatic nenous pressure gradient （HVPG） in combination group was （6.5±1.0） mmHg,much lower than （11.9±1.1）mmHg in the control,while RBC was （4.7±0.5）×10¹²/L,Hb was（118.5±23.1） g/L,significantly higher than （4.1±0.4）×10¹²/L and（104.4±22.5） g/L in the control（P<0.05）;the hemostasis time was（1.3±0.4） d,blood transfusion was （1.7±1.0）U,and hospital stay was（20.4±3.5） d,significantly shorter or less than （2.8±0.5） d,（2.8±1.5） U and （29.8±4.0） d in the control （P<0.05）;at the end of one-year follow-up,the incidences of rebleeding in the two groups were 53.1% and 86.2% （P<0.05）. Conclusion The emergent application of somatostatin and EVL in dealing with patients with liver cirrhosis complicated by EVB is efficient and safe, which can effectively achieve rapid hemostasis and shorten the hospitalization time.

Key words: Liver cirrhosis, Esophageal variceal bleeding, Endoscopic variceal ligation, Somatostatin, Therapy

甘厦,方念,黄神安,程飞,张海丽,万娟. 内镜套扎术联合生长抑素治疗肝硬化并发食管静脉曲张出血患者临床效果和安全性分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 236-239.

Gan Xia, Fang Nian, Huang Shen’an, Chen Fei, Zhang Haili, Wan Juan. Clinical therapeutic efficacy and safety of endoscopic variceal ligation combined with somatostatin in treatment of patients with liver cirrhosis complicated by esophageal variceal bleeding[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 236-239.

参考文献

[1] 黄利青. 倍他洛克联用奥美拉唑治疗肝炎肝硬化并发消化性溃疡患者疗效观察. 实用肝脏病杂志,2016,19(4):484-485.
[2] Han EC,Ryoo SB,Ji WP,et al.Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis:A propensity-matched study. Plos One,2017,12(6):e0178920.
[3] Liu L,Qin S,Zheng Y,et al.Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. Cancer Biol Therap,2017,18(3):166-176.
[4] Cazzo E,Gestic MA,Utrini MP,et al.Bariatric surgery in individuals with liver cirrhosis:A narrative review. Revista Da Associacao Medica Brasileira,2017,63(2):190-194.
[5] Valmasoni M,Pierobon ES,Pasqual CAD,et al.Esophageal cancer surgery for patients with concomitant liver cirrhosis:A single-center matched-cohort study. Ann Surg Oncol,2016,24(3):763-769.
[6] Nagata N,Niikura R,Yamada A,et al.Acute middle gastrointestinal bleeding risk associated with NSAIDs,antithrombotic drugs,and PPIs:A multicenter case-control study. Plos One,2016,11(3):e0151332.
[7] 张育,顾健,朱妍. 内科学. 科学出版社,1版,北京:2016:312-313.
[8] 中华医学会肝病学分会、消化病学分会、内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志,2016,19(5):Ⅰ-ⅩⅤⅠ.
[9] 中华医学会消化内镜学分会. 食管胃静脉曲张内镜下诊断和治疗规范试行方案(2003年). 中华消化内镜杂志,2004,21(3):149-151.
[10] Maeda E,Yamamoto N,Okano K,et al.Laparoscopic splenectomy for patients with liver cirrhosis:Improvement of long-term liver function in patients with Child-Pugh class B. HPB,2016,18(1):e148-e148.
[11] Peng Y,Qi X,Guo X.Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis:A systematic review and Meta-analysis of observational studies. Medicine,2016,95(8):e2877.
[12] 赵莉,许乐,赵莉,等. 内镜下套扎术治疗老年肝硬化患者食管静脉曲张的疗效观察. 中华老年医学杂志,2016,35(4):401-404.
[13] 吴武军,于咏田,杜立学,等. 脾腔小口径分流联合断流术对肝硬化门静脉高压症患者肝血流动力学和储备功能的影响. 实用肝脏病杂志,2016,19(2):196-199.
[14] 戴晏平,高青. 规范化内镜治疗肝硬化食管静脉曲张出血的预后分析. 中华肝脏病杂志,2017,25(3):195-199.
[15] Kawai T,Yashima Y,Sugimoto T,et al.Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis:a retrospective study. World J Surg Oncol,2016,14(1):52.
[16] Kang SH,Yim HJ,Kim SY,et al.Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation:A retrospective cohort study. Medicine,2016,95(8):e2903.
[17] Veitch AM,Vanbiervliet G,Gershlick AH,et al.Endoscopy in patients on antiplatelet or anticoagulant therapy,including direct oral anticoagulants:British Society of Gastroenterology(BSG) and European Society of Gastrointestinal Endoscopy(ESGE) guidelines. Gut,2016,65(3):374-389.
[18] Bhat YM,Weilert FF,Fredrick RT,et al.EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: a large U.S. experience over 6 years (with video). Gastrointest Endosc,2016,83(6):1164-1172.
[19] Gimovsky ML,Patel JK,Valthaty R,et al.Pregnancy complicated by cirrhosis,portal hypertension,and esophageal varices:A case report. J Reprod Med,2018,63(2):179-181.
[20] Burgess NG,Pellise M,Nanda KS,et al.Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut, 2016,65(3):437-446.

内镜套扎术联合生长抑素治疗肝硬化并发食管静脉曲张出血患者临床效果和安全性分析^*

Clinical therapeutic efficacy and safety of endoscopic variceal ligation combined with somatostatin in treatment of patients with liver cirrhosis complicated by esophageal variceal bleeding

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[2]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[3]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[4]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[5]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[6]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[7]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[8]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[9]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[10]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[11]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[12]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[13]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[14]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[15]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.